161 related articles for article (PubMed ID: 35243124)
1. A novel cervical cancer screen-triage-treat demonstration project with HPV self-testing and thermal ablation for women in Malawi: Protocol for a single-arm prospective trial.
Chinula L; McGue S; Smith JS; Saidi F; Mkochi T; Msowoya L; Varela A; Lee F; Gopal S; Chagomerana M; Tomoka T; Mwapasa V; Tang J
Contemp Clin Trials Commun; 2022 Apr; 26():100903. PubMed ID: 35243124
[TBL] [Abstract][Full Text] [Related]
2. Prevention of cervical cancer through two HPV-based screen-and-treat implementation models in Malawi: protocol for a cluster randomized feasibility trial.
Tang JH; Smith JS; McGue S; Gadama L; Mwapasa V; Chipeta E; Chinkhumba J; Schouten E; Ngwira B; Barnabas R; Matoga M; Chagomerana M; Chinula L
Pilot Feasibility Stud; 2021 Apr; 7(1):98. PubMed ID: 33879259
[TBL] [Abstract][Full Text] [Related]
3. Experiences of women participating in a human papillomavirus-based screen-triage-and treat strategy for cervical cancer prevention in Malawi.
Lee F; McGue S; Chapola J; Dunda W; Tang JH; Ndovie M; Msowoya L; Mwapasa V; Smith JS; Chinula L
Front Oncol; 2024; 14():1356654. PubMed ID: 38476363
[TBL] [Abstract][Full Text] [Related]
4. Design of the HPV-Automated Visual Evaluation (PAVE) Study: Validating a Novel Cervical Screening Strategy.
de Sanjosé S; Perkins RB; Campos NG; Inturrisi F; Egemen D; Befano B; Rodriguez AC; Jerónimo J; Cheung LC; Desai K; Han P; Novetsky AP; Ukwuani A; Marcus J; Ahmed SR; Wentzensen N; Kalpathy-Cramer J; Schiffman M;
medRxiv; 2023 Oct; ():. PubMed ID: 37693492
[TBL] [Abstract][Full Text] [Related]
5. Point-of-care HPV DNA testing of self-collected specimens and same-day thermal ablation for the early detection and treatment of cervical pre-cancer in women in Papua New Guinea: a prospective, single-arm intervention trial (HPV-STAT).
Vallely AJB; Saville M; Badman SG; Gabuzzi J; Bolnga J; Mola GDL; Kuk J; Wai M; Munnull G; Garland SM; Brotherton JML; Kelly-Hanku A; Morgan C; Toliman PJ; Kombati Z; Kariwiga G; Babona D; Tan G; Simms KT; Cornall AM; Tabrizi SN; Wand H; Guy R; Canfell K; Kaldor JM
Lancet Glob Health; 2022 Sep; 10(9):e1336-e1346. PubMed ID: 35878625
[TBL] [Abstract][Full Text] [Related]
6. Uptake and safety of community-based "screen-and-treat" with thermal ablation preventive therapy for cervical cancer prevention in rural Lilongwe, Malawi.
Chinula L; Topazian HM; Mapanje C; Varela A; Chapola J; Limarzi L; Stanley C; Hosseinipour M; Gopal S; Tang JH
Int J Cancer; 2021 Jul; 149(2):371-377. PubMed ID: 33687746
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus-based cervical cancer prevention: long-term results of a randomized screening trial.
Denny L; Kuhn L; Hu CC; Tsai WY; Wright TC
J Natl Cancer Inst; 2010 Oct; 102(20):1557-67. PubMed ID: 20884893
[TBL] [Abstract][Full Text] [Related]
8. Utility of extended HPV genotyping for the triage of self-sampled HPV-positive women in a screen-and-treat strategy for cervical cancer prevention in Cameroon: a prospective study of diagnostic accuracy.
Broquet C; Vassilakos P; Ndam Nsangou FM; Kenfack B; Noubom M; Tincho E; Jeannot E; Wisniak A; Petignat P
BMJ Open; 2022 Dec; 12(12):e057234. PubMed ID: 36549727
[TBL] [Abstract][Full Text] [Related]
9. Triage by methylation-marker testing versus cytology in women who test HPV-positive on self-collected cervicovaginal specimens (PROHTECT-3): a randomised controlled non-inferiority trial.
Verhoef VM; Bosgraaf RP; van Kemenade FJ; Rozendaal L; Heideman DA; Hesselink AT; Bekkers RL; Steenbergen RD; Massuger LF; Melchers WJ; Bulten J; Overbeek LI; Berkhof J; Snijders PJ; Meijer CJ
Lancet Oncol; 2014 Mar; 15(3):315-22. PubMed ID: 24529697
[TBL] [Abstract][Full Text] [Related]
10. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
[TBL] [Abstract][Full Text] [Related]
11. Triaging HPV-positive, cytology-negative cervical cancer screening results with extended HPV genotyping and p16
Song F; Yan P; Huang X; Wang C; Qu X; Du H; Wu R
BMC Infect Dis; 2021 Apr; 21(1):400. PubMed ID: 33931022
[TBL] [Abstract][Full Text] [Related]
12. Design and feasibility of a novel program of cervical screening in Nigeria: self-sampled HPV testing paired with visual triage.
Desai KT; Ajenifuja KO; Banjo A; Adepiti CA; Novetsky A; Sebag C; Einstein MH; Oyinloye T; Litwin TR; Horning M; Olanrewaju FO; Oripelaye MM; Afolabi E; Odujoko OO; Castle PE; Antani S; Wilson B; Hu L; Mehanian C; Demarco M; Gage JC; Xue Z; Long LR; Cheung L; Egemen D; Wentzensen N; Schiffman M
Infect Agent Cancer; 2020; 15():60. PubMed ID: 33072178
[TBL] [Abstract][Full Text] [Related]
13. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
Gilham C; Sargent A; Kitchener HC; Peto J
Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
[TBL] [Abstract][Full Text] [Related]
14. A comparison of screening tests for detection of high-grade cervical abnormalities in women living with HIV from Cameroon.
Castle PE; Ajeh R; Dzudie A; Kendowo E; Fuhngwa N; Simo-Wambo AG; Nsame D; Orock E; Hebert TM; Pierz AJ; Murokora D; Anastos K; Adedimeji A
Infect Agent Cancer; 2020; 15():45. PubMed ID: 32676125
[TBL] [Abstract][Full Text] [Related]
15. Protocol for Compass: a randomised controlled trial of primary HPV testing versus cytology screening for cervical cancer in HPV-unvaccinated and vaccinated women aged 25-69 years living in Australia.
Canfell K; Saville M; Caruana M; Gebski V; Darlington-Brown J; Brotherton J; Heley S; Castle PE
BMJ Open; 2018 Jan; 8(1):e016700. PubMed ID: 29374658
[TBL] [Abstract][Full Text] [Related]
16. [A study of cervical cancer screening algorithms].
Zhao FH; Zhang WH; Pan QJ; Zhang X; Chen W; Liu B; Ma JF; Hu SY; Qiao YL
Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):420-4. PubMed ID: 20819481
[TBL] [Abstract][Full Text] [Related]
17. Community-based HPV self-collection versus visual inspection with acetic acid in Uganda: a cost-effectiveness analysis of the ASPIRE trial.
Mezei AK; Pedersen HN; Sy S; Regan C; Mitchell-Foster SM; Byamugisha J; Sekikubo M; Armstrong H; Rawat A; Singer J; Ogilvie GS; Kim JJ; Campos NG
BMJ Open; 2018 Jun; 8(6):e020484. PubMed ID: 29895648
[TBL] [Abstract][Full Text] [Related]
18. Pooled analysis of a self-sampling HPV DNA Test as a cervical cancer primary screening method.
Zhao FH; Lewkowitz AK; Chen F; Lin MJ; Hu SY; Zhang X; Pan QJ; Ma JF; Niyazi M; Li CQ; Li SM; Smith JS; Belinson JL; Qiao YL; Castle PE
J Natl Cancer Inst; 2012 Feb; 104(3):178-88. PubMed ID: 22271765
[TBL] [Abstract][Full Text] [Related]
19. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of human papilloma virus-DNA test verses colposcopy as secondary cervical cancer screening test to triage screen positive women on primary screening by visual inspection with 5% acetic acid.
Pimple S; Shastri SS
Indian J Cancer; 2014; 51(2):117-23. PubMed ID: 25104191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
